Today: 21 May 2026
Visa stock price slips after-hours as Senate swipe-fee amendment chatter meets earnings countdown
28 January 2026
2 mins read

Visa stock price slips after-hours as Senate swipe-fee amendment chatter meets earnings countdown

NEW YORK, Jan 27, 2026, 19:10 EST — After-hours

  • Visa shares fell roughly 1% in after-hours trading amid Washington’s scrutiny of a credit-card routing amendment
  • The Senate Agriculture Committee is slated to hold a markup on Jan. 29, where a Marshall-Durbin amendment aimed at limiting network exclusivity will be considered
  • Visa will hold its fiscal first-quarter earnings call on Jan. 29

Shares of Visa Inc dipped in after-hours trading Tuesday as investors digested changing prospects for a U.S. credit-card routing mandate and braced for the payments processor’s quarterly report due later this week.

This issue hits at the heart of Visa’s main business—routing rules. If credit cards are pushed to offer more network options, it could squeeze the fees Visa collects on its rails. The stock often moves quickly whenever this bill seems likely to get bundled into broader legislation.

This week features a crowded schedule. Thursday pits a Senate committee markup against Visa’s earnings report, forcing traders to balance policy news with corporate updates.

Visa shares dropped roughly 1% to $325.26. Mastercard slid around 1.3%, and American Express edged down about 1% in late trading.

The Senate Agriculture Committee set a business meeting for Thursday, Jan. 29 at 10:30 a.m. to discuss the Digital Commodity Intermediaries Act, the committee’s hearing notice reveals. It also outlines several proposed amendments.

Sen. Roger Marshall’s amendment would bar credit card networks and major issuers from demanding exclusivity on credit cards, according to the text. It targets issuers holding over $100 billion in assets and blocks any rules forcing transactions onto a single network.

Politico and Punchbowl News reported that Marshall has decided not to push the routing amendment at the markup, the ABA Banking Journal noted, even though it’s still listed on the committee’s website. The trade outlet added that Politico said the White House is pushing to get the underlying bill out of committee.

Morgan Stanley analyst James Faucette told clients the latest update “should assuage near-term fears” about the Credit Card Competition Act and “makes the networks easier to buy,” according to Investing.com. If 10% of U.S. credit volumes shift and pricing pressure cuts fees, Morgan Stanley projects Visa could see a roughly 3.5% revenue hit in 2026.

On the Street, Cantor Fitzgerald’s Ramsey El-Assal kicked off coverage of Visa with an Overweight rating and a $400 price target, Benzinga reported. The analyst also began coverage of Mastercard, assigning it an Overweight rating and a $650 target, the report added.

Visa has scheduled its fiscal first-quarter 2026 earnings call for Thursday at 5 p.m. ET. Investors will be zeroing in on payment volumes, cross-border travel spending, and any news on pricing or expenses.

Outside Washington, Visa continued to roll out marketing and sponsorship updates. On Monday, it launched a U.S. campaign for Milano Cortina 2026, featuring athletes Mikaela Shiffrin and Oksana Masters, the company announced.

Visa further connected the infrastructure for digital-asset cashouts. On Jan. 26, Mercuryo announced a partnership with Visa to broaden crypto-to-fiat “off-ramping” via Visa Direct. Visa Direct executive Anastasia Serikova described the move as “building bridges between the crypto space and the traditional financial system.” FF News | Fintech Finance

Visa’s sponsorship division made another play in women’s football. On Monday, FIFA announced Visa as a global sponsor for the inaugural FIFA Women’s Champions Cup 2026. Andrea Fairchild, a Visa executive, said the company was “proud to expand” its relationship with FIFA. Inside FIFA

The policy story can shift fast. Should Marshall step down, traders will be alert for another senator to take up the routing language. They’ll also keep an eye on how the committee deals with amendments affecting payments compared to crypto market structure.

Thursday brings two key events: the Senate Agriculture Committee meets at 10:30 a.m., followed by Visa’s earnings call at 5 p.m. ET. Investors will be watching closely for any changes in the regulatory outlook and Visa’s take on spending trends and cross-border demand.

Stock Market Today

  • EnerSys Q1 CY2026 Sales Beat Estimates with Optimistic Guidance
    May 20, 2026, 6:18 PM EDT. Battery maker EnerSys (NYSE:ENS) reported Q1 CY2026 sales of $988 million, up 1.4% year on year, beating analyst estimates by 1.5%. Adjusted earnings per share (EPS) stood at $3.19, a 6.6% beat over consensus. Guidance for Q2 revenue is $935 million, 2.2% above estimates, with adjusted EPS guidance also exceeding forecasts. Despite a 6% decline in sales volumes, revenue growth was supported by price increases. Free cash flow turned negative at -$12.66 million, down from $105 million last year. EnerSys continues to push its lithium data center and battery energy storage system solutions, signaling long-term innovation. The company's subdued 4.7% annualized revenue growth over five years contrasts with sector expectations, raising caution among investors.

Latest articles

AEVEX Stock Jumps After Hours as Drone Maker Posts 307% Revenue Surge and New Air Force Deal

AEVEX Stock Jumps After Hours as Drone Maker Posts 307% Revenue Surge and New Air Force Deal

21 May 2026
AEVEX Corp. shares surged over 10% after hours Wednesday following a first-quarter profit of $21 million and new U.S. Air Force contracts worth $15.6 million. Revenue jumped to $216.7 million, beating estimates. The company, which went public in April, raised its full-year revenue outlook to $600–$620 million. The stock had closed regular trading at $26.27, down 0.23%.
Jupiter Neurosciences Stock Swings on $100M MDMA Pact, $2M Equity Sale

Jupiter Neurosciences Stock Swings on $100M MDMA Pact, $2M Equity Sale

21 May 2026
Jupiter Neurosciences shares fell 37% to $0.205 Wednesday after announcing a proposed U.S. licensing deal for PharmAla Biotech’s MDMA-based ALA-002 and a $2 million stock offering. Trading volume topped 230 million shares. The licensing agreement is non-binding, with a potential value over $100 million, and gives Jupiter 90 days to finalize terms. Jupiter reported a $2.06 million Q1 net loss and $2.36 million in cash.
Urban Outfitters Stock Swings After Record Q1—What Nuuly and Tariffs Are Telling Investors

Urban Outfitters Stock Swings After Record Q1—What Nuuly and Tariffs Are Telling Investors

21 May 2026
Urban Outfitters posted record first-quarter net income of $115.7 million and sales of $1.48 billion, beating analyst estimates. Shares closed up 4.05% at $71.67 before slipping to $70.55 in after-hours trading. Comparable retail sales rose 5.6%, with strong gains at FP Group, Urban Outfitters, and Nuuly. Gross profit rate edged down to 36.6% as tariffs pressured costs.
Oracle stock slides 4% as AI spending scrutiny builds ahead of Fed decision
Previous Story

Oracle stock slides 4% as AI spending scrutiny builds ahead of Fed decision

Johnson & Johnson stock climbs after fresh FDA Darzalex Faspro nod — what investors watch next
Next Story

Johnson & Johnson stock climbs after fresh FDA Darzalex Faspro nod — what investors watch next

Go toTop